IP Library Granted Patent US 8,614,335
Granted Patent B2
US 8,614,335 · App. 12/191,518 · Granted Dec 24, 2013

Process and intermediates useful in the preparation of statins, particularly atorvastatin

Inventors: David John Moody (Fife, GB); Jonathan William Wiffen (Craigavon, GB)
Assignee: Redx Pharma Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,614,335
App. No.
12/191,518
Granted
Dec 24, 2013
Kind
B2
Abstract

There is provided a process for the preparation of a compound of formula (7) or salts thereof: wherein R 1 represents a hydrogen or a hydrocarbyl group, R 2 represents a hydrogen or substituent group, R 3 represents a hydrogen or a hydrocarbyl group, and X represents a hydrogen or substituent group which comprises a) cyanating a compound of formula (1): wherein Y represents a halo group, preferably CI or Br; P 1 represents hydrogen or a protecting group, and W represents ═O or —OP 2 , in which P 2 represents hydrogen or a protecting group, to give a compound of formula (2): b) reducing the compound of formula (2) to give a compound of formula (3): coupling the compound of formula (3) with a compound of formula (4): to give a compound of formula (5): when W represents —OP 2 , deprotecting and then oxidizing the compound of formula (5) to give a compound of formula (6): and e) subjecting the compound of formula (5) when W represents ═O, or compound of formula (6) to ring-opening, and removal of any remaining protecting groups, to give a compound of formula (7) or salts thereof.

Claims (29)

1. A process for the preparation of a compound of formula (7) or a salt thereof:

wherein

R 1 represents an alkyl group;

R 2 represents an aryl group;

R 3 represents an aryl group;

X represents a group of formula —COZ, wherein Z represents —OR 4 , in which R 4 represents alkyl, or —NR 5 R 6 , wherein R 5 and R 6 each independently represent H, alkyl, or aryl;

which comprises

a) cyanating a compound of formula (1):

wherein Y represents a halo group; P 1 represents hydrogen or a protecting group, and W represents —OP 2 , in which P 2 represents hydrogen or a protecting group, to give a compound of formula (2):

b) reducing the compound of formula (2) to give a compound of formula (3):

c) coupling the compound of formula (3) with a compound of formula (4):

to give a compound of formula (5):

d) deprotecting and then oxidising the compound of formula (5) to give a compound of formula (6):

and

e) subjecting the compound of formula (6) to ring-opening, and removal of any remaining protecting groups, to give a compound of formula (7) or a salt thereof:

2. The process according to claim 1 , wherein R 1 is an isopropyl group, R 2 is a phenyl group, R 3 is a 4-fluorophenyl group, and X is —CO 2 Me, —CO 2 Et or —CONHPh.

3. The process of claim 1 , wherein Y represents Cl or Br.

4. The process of claim 1 , wherein R 1 represents a C 1-6 alkyl group.

5. The process of claim 1 , wherein R 1 represents an isopropyl group.

6. The process of claim 1 , wherein R 2 represents a phenyl group.

7. The process of claim 1 , wherein R 3 represents a 4-fluorophenyl group.

8. The process of claim 1 , wherein Z represents —OR 4 , in which R 4 represents alkyl.

9. The process of claim 1 , wherein Z represents —OR 4 , in which R 4 represents a methyl or ethyl group.

10. The process of claim 1 , wherein Z represents —NR 5 R 6 , wherein R 5 and R 6 each independently represent H, alkyl, or aryl.

11. The process of claim 1 , wherein Z represents —NR 5 R 6 , wherein R 5 is H, and R 6 is phenyl.

12. The process of claim 1 , wherein R 1 represents a C 1-6 alkyl group; and R 2 represents a phenyl group.

13. The process of claim 1 , wherein R 1 represents a C 1-6 alkyl group; R 2 represents a phenyl group; and R 3 represents a 4-fluorophenyl group.

14. The process of claim 1 , wherein R 1 represents a C 1-6 alkyl group; R 2 represents a phenyl group; R 3 represents a 4-fluorophenyl group; and Z represents —OR 4 , in which R 4 represents a methyl or ethyl group.

15. The process of claim 1 , wherein R 1 represents a C 1-6 alkyl group; R 2 represents a phenyl group; R 3 represents a 4-fluorophenyl group; and Z represents —NR 5 R 6 , wherein R 5 is H, and R 6 is phenyl.

Assignments (7)
CHANGE OF NAME Recorded Apr 17, 2015
From: REDX PHARMA LIMITED
To: REDX PHARMA PLC
Reel/Frame 035455/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2013
From: MOODY, DAVID JOHN; WIFFEN, JONATHAN WILLIAM
To: AVECIA PHARMACEUTICALS LIMITED
Reel/Frame 031660/0148 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2013
From: MOODY, DAVID JOHN; WIFFEN, JONATHAN WILLIAM
To: AVECIA PHARMACEUTICALS LIMITED
Reel/Frame 031661/0497 →
CHANGE OF NAME Recorded Nov 22, 2013
From: AVECIA PHARMACEUTICALS LIMITED
To: NPIL PHARMACEUTICALS (UK) LIMITED
Reel/Frame 031718/0545 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2011
From: BRADFORD PHARMA LIMITED
To: REDX PHARMA LIMITED
Reel/Frame 027221/0001 →
CHANGE OF NAME Recorded Mar 3, 2010
From: NPIL PHARMACEUTICALS (UK) LIMITED
To: PIRAMAL HEALTHCARE UK LIMITED
Reel/Frame 024021/0384 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2010
From: PIRAMAL HEALTHCARE UK LIMITED
To: BRADFORD PHARMA LIMITED
Reel/Frame 024021/0412 →
Priority Claims (2)
GB 0317393.7 · Jul 25, 2003 · national
GB 0406760.9 · Mar 26, 2004 · national
Continuity (2)
Division 10563459
Related Publication 20090062553A1 · Mar 5, 2009